1. |
Tanaka H, Hirohashi K, Kubo S, et al. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function \[J\]. Br J Surg, 2000; 87(7)∶879.
|
2. |
葛敦鈞, 錢 峰. 肝癌預治療后二期切除時機的探討 \[J\]. 中華肝膽外科雜志, 1998; 5(5)∶331.
|
3. |
Shimamura T, Nakajima Y, Une Y, et al. Efficacy and safety of preoperative percutaneous transhepatic portal embolization with absolute ethanol: a clinical study \[J\]. Surgery, 1997; 121(2)∶135.
|
4. |
湯釗猷主編. 原發性肝癌研究與進展 \[M\]. 上海: 上海醫科大學出版社, 1990∶86~89.
|
5. |
陸 森, 錢建民, 黃海清, 等. 幾種不同預測大鼠肝臟體積(重量)方法的比較 \[J\]. 中華實驗外科雜志, 2002; 19(3)∶252.
|
6. |
Rocheleau B, Ethier C, Houle R, et al. Hepatic artery buffer response following left portal vein ligation: its role in liver tissue homeostasis \[J\]. Am J Physiol, 1999; 277(5 Pt 1)∶G1000.
|
7. |
Yokoyama Y, Baveja R, Sonin N, et al. Hepatic neovascularization after partial portal vein ligation: novel mechanism of chronic regulation of blood flow \[J\]. Am J Physiol Gastrointest Liver Physiol, 2001; 280(1)∶21.
|
8. |
Bilodeau M, Aubry MC, Houle R, et al. Evaluation of hepatocyte injury following partial ligation of the left portal vein \[J\]. J Hepatol, 1999; 30(1)∶29.
|
9. |
Fausto N, Laird AD, Webber EM. Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration \[J\]. FASEB J, 1995; 9(15)∶1527.
|
10. |
Picard C, Starkel P, Sempoux C, et al. Molecular mechanisms of apoptosis in the liver of rats after portal branch ligation with and without retrorsine \[J\]. Lab Invest, 2004; 84(5)∶618.
|
11. |
Hashimoto M, Watanabe G. Changes in functional capacity after portal branch ligation in rats \[J\]. Surg Today, 2001; 31(12)∶1065.
|
12. |
Schwartz JD, Schwartz M, Mandeli J, et al. Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials \[J\]. Lancet Oncol, 2002; 3(10)∶593.
|
13. |
Elias D, Debaere T, Roche A, et al. Preoperative selective portal vein embolizations are an effective means of extending the indications of major hepatectomy in the normal and injured liver \[J\]. Hepatogastroenterology, 1998; 45(19)∶170.
|
14. |
Taniguchi H, Daidoh T, Shioaki Y, et al. Blood supply and drug delivery to primary and secondary human liver cancers studied with in vivo bromodeoxyuridine labeling\[J\]. Cancer, 1993; 71(1)∶50.
|
15. |
Kinoshita H, Sakai K, Hirohashi K, et al. Preoperative portal vein embolization for hepatocellular carcinoma \[J\].World J Surg, 1986; 10(5)∶803.
|
16. |
Castaing D, Garden OJ, Bismuth H. Segmental liver resection using ultrasound-guided selective portal venous occlusion \[J\]. Ann Surg, 1989; 210(1)∶20.
|
17. |
Matsumata T, Kanematsu T, Takenaka K, et al. Lack of intrahepatic recurrence of hepatocellular carcinoma by temporary portal venous embolization with starch microspheres \[J\]. Surgery, 1989; 105(2 Pt 1)∶188.
|